Nasogastric/Orogastric Tube Placement Confirmation in Neonates Utilizing Self-contained pH Device, a Feasibility Study
This study is looking at using a self-contained pH device that will assist in confirming placement of a nasogastric or orogastric tube placed in the stomach of hospitalized infants.
- EligibilityCriteria: Inclusion Criteria:  All patients admitted to the NICU at the University of Minnesota Masonic Children's Hospital, Minneapolis, MN requiring placement of an NG/OG tube are eligible to enroll.  Exclusion Criteria:  Participant deemed unsuitable for study by the treating provider. Participants who are on the following medications: proton-pump inhibitor (PPI's) or H2 blockers within one week prior to the device assessment. - HealthyVolunteers: No - Gender: All - MaximumAge: 2 Years - StdAgeList: Child - StudyPopulation: Infants admitted to the University of Minnesota Masonic Children's Hospital neonatal intensive care unit. - SamplingMethod: Non-Probability Sample